Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Hims & Hers Health Inc. sell UBS Group AG

Start price
€35.55
26.06.25 / 50%
Target price
-
26.06.26
Performance (%)
34.43%
Price
€47.79
09:31
Summary
This prediction is currently active. The SELL prediction by UBS_Group_AG for Hims & Hers Health Inc. is trending in the completely wrong direction and now has a performance of 34.43%. This prediction currently runs until 26.06.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Hims & Hers Health Inc. 1.920% 1.920%
iShares Core DAX® 1.631% -0.020%
iShares Nasdaq 100 1.073% 5.074%
iShares Nikkei 225® -0.615% 5.550%
iShares S&P 500 1.061% 3.163%

Comments by UBS_Group_AG for this prediction

In the thread Hims & Hers Health Inc. diskutieren

Hims & Hers Health, Inc. (NYSE: HIMS) had its "underperform" rating re-affirmed by analysts at UBS Group AG.
Ratings data for HIMS provided by MarketBeat